Due to U.S. funding cuts and related national budget reprioritizations, the Indonesian tuberculosis response program announced a 90% reduction in travel-related expenditures and a 50% reduction in human resource costs supported for 2026. Core functions such as monitoring and evaluation, supervision and capacity-building have been significantly impacted as a result.
Date: 11/25
Region: East Asia & Pacific
Country: Indonesia
Topic: Health
Policy Lens: Global Health Security
Entry Type: Operational Impact
Additional Context: This information was included in the “The impact of 2025 funding cuts on TB services” annex of the World Health Organization's, or WHO, 2025 Global Tuberculosis Report. Examples of expenditure decreases include the shift of training and supervision activities to online platforms, and the adjustment of diagnostic algorithms to reduce the quantity of molecular WHO-recommended rapid diagnostic tests being used. In 2024, USAID accounted for 9.7% of Indonesia’s tuberculosis funding and the Global Fund for a further 41%.
Devex Researcher Note: At the time of the Global Fund's eighth replenishment summit, to which the U.S. committed $4.6 billion — down from its $6 billion pledge in the seventh cycle — it had disbursed only $3.12 billion of that prior commitment, forcing mid-cycle grant cuts of 10% or more across the majority of recipient countries. The exact magnitude of effects on Indonesia are not immediately clear. The Indonesian government has taken these measures to prioritize life-saving interventions, while navigating a funding gap exceeding 40% for necessary tuberculosis services.
Source: WHO

